BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12672268)

  • 21. [A new methylhydrazine derivative (Ro 4-6467 or Natulan) in the treatment of Hodgkin's disease. Study of 10 cases].
    da Silva MP; Kerbauy J; de Guerra CC
    Rev Bras Med; 1966 Jul; 23(7):483-9. PubMed ID: 6014416
    [No Abstract]   [Full Text] [Related]  

  • 22. Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
    Zinzani PL; Martelli M; Poletti V; Vitolo U; Gobbi PG; Chisesi T; Barosi G; Ferreri AJ; Marchetti M; Pimpinelli N; Tura S; ; ;
    Haematologica; 2008 Sep; 93(9):1364-71. PubMed ID: 18603558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Multiple drug therapy in Hodgkin's disease, lymphosarcoma and reticulosarcoma].
    Con I; Daiber A; Donoso A; Osorio G; Mora F
    Rev Med Chil; 1972 Apr; 100(4):408-13. PubMed ID: 4557485
    [No Abstract]   [Full Text] [Related]  

  • 24. 49th Annual Meeting of the American Society of Hematology, Atlanta, GA; December 8-11, 2007.
    Clin Lymphoma Myeloma; 2008 Apr; 8(2):77-86. PubMed ID: 18564453
    [No Abstract]   [Full Text] [Related]  

  • 25. [Standard treatment of malignant lymphoma (Hodgkin's and non-Hodgkin's lymphoma)].
    Hotta T
    Nihon Naika Gakkai Zasshi; 2001 Jun; 90(6):997-1002. PubMed ID: 11460390
    [No Abstract]   [Full Text] [Related]  

  • 26. Status and perspectives in chemotherapy of Hodgkin's disease.
    Frei E
    Arch Intern Med; 1973 Mar; 131(3):439-45. PubMed ID: 4739436
    [No Abstract]   [Full Text] [Related]  

  • 27. Highlights in Lymphoma From the 2015 ASH Meeting: Commentary.
    Chen RW
    Clin Adv Hematol Oncol; 2016 Feb; 14(2 Suppl 1):18-23. PubMed ID: 27007009
    [No Abstract]   [Full Text] [Related]  

  • 28. Paclitaxel in the salvage treatment of Hodgkin's disease and non-Hodgkin's lymphoma.
    Hopfinger G; Heinz R; Pfeilstöcker M; Schlögl E; Waldner R; Pittermann E
    Ann Oncol; 1996 Apr; 7(4):423-4. PubMed ID: 8805938
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevalence of co-morbidity and its relationship to treatment among unselected patients with Hodgkin's disease and non-Hodgkin's lymphoma, 1993-1996.
    van Spronsen DJ; Janssen-Heijnen ML; Breed WP; Coebergh JW
    Ann Hematol; 1999 Jul; 78(7):315-9. PubMed ID: 10466443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of patients with non-Hodgkin's lymphoma.
    Carbone PP
    Arch Intern Med; 1973 Mar; 131(3):455-9. PubMed ID: 4569377
    [No Abstract]   [Full Text] [Related]  

  • 31. Leurosine sulfate (NSC-90636) in treatment of Hodgkin's disease, acute lymphoblastic leukemia, and lymphoblastic lymphosarcoma.
    Mathe G; Schneider M; Bond P; Amiel JL; Schwarzenberg L; Cattan A; Schlumberger JR
    Cancer Chemother Rep; 1965 Dec; 49():47-9. PubMed ID: 5322839
    [No Abstract]   [Full Text] [Related]  

  • 32. [Leurosine, the 3d alkaloid from Vinca rosea, in the treatmen t of Hodgkin's disease, acute lymphoblastic leukemia and lymphoblastosarcoma].
    Schneider M; Band P; Amiel JL; Schwarzenberg L; Cattan A; Schlumberger JR; Mathé G
    Sem Hop; 1966 Nov; 42(49):2952-4. PubMed ID: 4292621
    [No Abstract]   [Full Text] [Related]  

  • 33. Recent advances in chemotherapy of the lymphomas: a review.
    Williams CK
    Afr J Med Med Sci; 1987 Dec; 16(4):163-9. PubMed ID: 2830776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term follow-up of Hodgkin's disease and unfavorable type of non-Hodgkin's lymphoma].
    Sampi K; Maseki N; Sakurai M; Hattori M
    Rinsho Ketsueki; 1988 Feb; 29(2):144-8. PubMed ID: 3385941
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of Hodgkin's disease and other malignant lymphomas.
    Aungst CW
    J Surg Oncol; 1973 Jun; 5(6):575-9. PubMed ID: 4589653
    [No Abstract]   [Full Text] [Related]  

  • 36. 37th Annual American Society of Clinical Oncology Meeting. San Francisco, CA. May 12-15, 2001.
    D'Orazio AI
    Clin Lymphoma; 2001 Jun; 2(1):11-7. PubMed ID: 11712543
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.
    Bokemeyer C; Schmoll HJ; van Rhee J; Kuczyk M; Schuppert F; Poliwoda H
    Ann Hematol; 1994 Mar; 68(3):105-10. PubMed ID: 8167175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral non-Hodgkin's lymphoma discovered when treating Hodgkin's disease.
    Bergeron C; Le Moine P; Le Prise-Fleury E; Jouan H; Tass P; Darcel F; Chatel M; Edan C; Patte C; Faivre J
    Med Pediatr Oncol; 1993; 21(4):307-10. PubMed ID: 8469228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of high-dose chemotherapy in patients with Hodgkin's disease and non-Hodgkin's lymphoma.
    Laport GF; Williams SF
    Semin Oncol; 1998 Aug; 25(4):503-17. PubMed ID: 9728600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Results of combined chemotherapy of malignant lymphoma at the hematological department of the clinical hospital in Belgrade].
    Plécas V; Dragović M; Vidaković B; Jelić S; Obradović M
    Srp Arh Celok Lek; 1976 Sep; 104(9):645-52. PubMed ID: 800287
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.